Form 4 for XTNT Xtant Medical Holdings, Inc.
Accepted 2023-05-16 00:00:00 ET · period of report 2023-05-15 · accession 0001235802-23-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-16 | 2023-05-15 | XTNT | Beeson Jonn R. | Dir | A - Grant | $0.00 | +52.0K | 52.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | A | A | 52,049 | $0.00 | 52,049 | D | — | — | (F1) These shares are subject to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Second Amended and Restated 2018 Equity Incentive Plan, (as amended from time to time), and vest and become issuable on May 15, 2024, conditioned upon the Reporting Person remaining a director of Xtant through the vesting date. |